Washington: US President Donald Trump and top health officials are expected to announce Monday that autism may be linked to the use of Tylenol, also known as paracetamol or acetaminophen, during pregnancy, reviving a medical controversy dismissed by many experts.

According to Anadolu Agency, the announcement is set to reignite debate over the use of acetaminophen, Tylenol's active ingredient, during early pregnancy. This debate was first reported by the Wall Street Journal earlier this month.

Health Secretary Robert F. Kennedy Jr., who has previously promoted debunked theories about autism, stated that a government report on the disorder's causes would be released this month.

In response to the anticipated announcement, Kenvue, the maker of Tylenol, issued a statement asserting their position: "We believe independent, sound science clearly shows that taking acetaminophen does not cause autism. We strongly disagree with any suggestion otherwise and are deeply concerned with the health risk this poses for expecting mothers."